Nucleolin regulates gene expression in CD34-positive hematopoietic cells

Area of Science:

• Hematology
• Molecular Biology
• Gene Regulation

Background:

• CD34 glycoprotein is essential for human hematopoiesis, found on progenitor cells with self-renewal and differentiation capabilities.
• Nucleolin, a phosphoprotein in growing eukaryotic cells, regulates gene transcription and chromatin remodeling, with enriched transcripts in stem cells.

Purpose of the Study:

• To investigate the role of nucleolin in regulating CD34 and Bcl-2 gene expression in human CD34-positive hematopoietic cells.
• To elucidate the mechanism by which nucleolin influences CD34 expression and hematopoietic stem/progenitor cell maintenance.

Main Methods:

• Analysis of nucleolin's effect on endogenous CD34 and Bcl-2 gene expression in CD34-positive cells.
• Investigation of nucleolin's direct interaction with the CD34 promoter region using sequence-specific methods.
• Comparison of nucleolin expression and promoter recruitment in CD34-positive mobilized peripheral blood cells versus CD34-negative peripheral blood mononuclear cells.

Main Results:

• Nucleolin activates endogenous CD34 and Bcl-2 gene expression in human CD34-positive hematopoietic cells.
• Nucleolin enhances cell surface CD34 protein expression by directly binding to the CD34 promoter region.
• Nucleolin expression is higher in CD34-positive mobilized peripheral blood cells, with recruitment to the CD34 promoter, unlike in CD34-negative cells.

Conclusions:

• Nucleolin functions as a key regulator in the gene expression program of CD34-positive hematopoietic cells.
• The findings provide insights into the maintenance mechanisms of human CD34-positive hematopoietic stem and progenitor cells.
• Nucleolin's role in activating CD34 and Bcl-2 expression is critical for hematopoietic stem cell function and maintenance.